Poster at German Cancer Congress 2018!

The abstract "Quality of life and patient-reported early adverse effects in prostate cancer patients treated with radiotherapy in the multi-center observational REQUITE study" , Petra Seibold, et. al. was accepted as poster for the German Cancer Congress. The Deutscher Krebskongress (German Cancer Congress) is the largest and oldest congress covering cancer diagnostics and therapy in German-speaking countries. The 33rd German Cancer Congress took place from February 21 to 24, 2018, in Berlin.

The researchers assessed the relationship between patient-reported early adverse effects (AEs) and health related worsening of quality of life (QoL) among prostate cancer patients. To read the abstract click here. All the accepted Abstracts are published in supplement 1 from the journal "Oncology Research and Treatment".